Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huatuo Zaizao pills for neurologic dysfunction after cerebral small vessel disease
ChiCTR2000039468Phase 4Recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Sep 2019
- Countries
- 1
01
Overview
Phase 4, open-label trial of Huatuo Zaizao in Cerebral Small Vessel Disease (CSVD), vascular cognitive disorder (VCD) and vascular parkinsonism (VP) (4 arms), sponsored by Beijing Friendship Hospital. Primary endpoints: Activities of Daily Living (ADL), Mini-Mental State Examination (MMSE) and 6 more. Started Sep 2019; status: recruiting.
02
Drugs
Huatuo Zaizao
03
Conditions
Cerebral Small Vessel Disease (CSVD)vascular cognitive disorder (VCD)vascular parkinsonism (VP)
Beyond the preview
Go deeper on ChiCTR2000039468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039468.